Islamic fasting: cardiovascular disease perspective

Expert Rev Cardiovasc Ther. 2022 Oct;20(10):795-805. doi: 10.1080/14779072.2022.2138344. Epub 2022 Oct 24.

Abstract

Introduction: Ramadan is a month of obligatory fasting observed by the majority of 2 billion Muslims living around the globe. The guidelines for 'risk-free' fasting exist for chronic diseases, including diabetes mellitus, but recommendations for cardiovascular disease (CVD) patients are deficient due to the paucity of literature.

Areas covered: Databases were screened to find relevant studies for an evidence-based consensus regarding the risk stratification and management of CVD. Using practical guidelines of the European Society of Cardiology (ESC), we categorized patients into low-, moderate-, and high-risk categories and proposed a pre-Ramadan checklist for the assessment of cardiac patients before fasting. Regular moderate-intensity exercise is recommended for most cardiac patients, which has been demonstrated to provide an anti-inflammatory and antioxidant effect that improves immune function.

Expert opinion: In Ramadan, many physiological changes occur during fasting, which brings about a balanced metabolic homeostasis of the body. In addition, Ramadan fasting is a nonpharmacologic means of decreasing CV risk factors. As Islam exempts Muslims from fasting if they are unwell; therefore, patients with the acute coronary syndrome (ACS), advanced heart failure (HF), recent percutaneous coronary intervention (PCI), or cardiac surgery should avoid fasting.

Keywords: heart failure; intermittent fasting; ischemic heart disease; ramadan fasting.

MeSH terms

  • Cardiovascular Diseases* / prevention & control
  • Diabetes Mellitus*
  • Fasting / adverse effects
  • Humans
  • Islam
  • Percutaneous Coronary Intervention*